首页> 外文期刊>International Journal of Pharmaceutics >Characterization of potential NMDA and cholecystokinin antagonists I. acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels.
【24h】

Characterization of potential NMDA and cholecystokinin antagonists I. acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels.

机译:潜在的NMDA和胆囊收缩素拮抗剂的表征I. 2-甲基-4-氧代-3H-喹唑啉-3-烷基-羧酸在分子和亚分子水平的酸碱性质。

获取原文
获取原文并翻译 | 示例
           

摘要

The protonation macroconstants (log K) of 4(3H)-quinazolone (1) and two 2-methyl-4-oxo-3H-alkyl-quinazoline-3-carboxylic acid derivatives (2,3) were determined by pH-potentiometry. The acid-base chemistry of compounds 2 and 3, where proton-bindings take place in an overlapping fashion, was described in terms of protonation microconstants as well. Microspeciation was carried out by two means: UV-pH titration (selective, pH-dependent monitoring of the N1-binding site), and deductively (using a derivative compound as covalently fixed model of one of the protonation isomers). The microconstant values obtained by the two different methods are in agreement within 0.05 log K units. Microspeciation revealed remarkable differences between the two homologue compounds (2 and 3). The microconstant values show that insertion of a second methylene moiety into the aliphatic acid side-chain (1) increases the electron-density and most basicity parameters of both functional groups; (2) significantly modifies the extent of site-site interactions in the molecule; (3) opens new conformational preferences by N1 ring nitrogen-carboxylic group intramolecular hydrogen bond formation and (4) reverses the predominantly zwitterion-involved protonation pathway into a neutral form-involved pathway. These molecules exemplify that microconstant values allow the comparative prediction and quantitative evaluation of pharmacokinetic behaviour, and signify the fact that microspeciation is a powerful tool in the process of drug development.
机译:通过pH电位法测定4(3H)-喹唑酮(1)和两个2-甲基-4-氧代-3H-烷基-喹唑啉-3-羧酸衍生物(2,3)的质子化大常数(log K)。还以质子化微常数描述了化合物2和3的酸碱化学,其中质子结合以重叠的方式发生。微观形成通过两种方式进行:UV-pH滴定(选择性,依赖pH的N1结合位点监测)和演绎性(使用衍生化合物作为质子化异构体之一的共价固定模型)。通过两种不同方法获得的微常数值在0.05 log K单位内一致。显微形成揭示了两种同系物化合物(2和3)之间的显着差异。微常数值表明,第二个亚甲基部分插入脂肪酸侧链(1)中会增加两个官能团的电子密度和大多数碱性参数; (2)显着改变分子中位点-位点相互作用的程度; (3)通过N1环氮-羧基基团分子内氢键的形成打开了新的构象偏好,(4)将主要由两性离子参与的质子化途径逆转为中性形式。这些分子表明,微常数值可以对药代动力学行为进行比较预测和定量评估,并表明微形态学是药物开发过程中强大的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号